How we work
Every article on Vitenta follows the same method. We describe it here so you can judge for yourself how much it deserves your trust.
We start from the official source
Every question gets an answer based on the official prescribing information approved by the EMA or local authorities (MHRA, NICE, FDA). We cite the relevant section and link to it. We do not interpret, add to, or omit from it.
We add real experience
We describe patterns we observe in the GLP-1 user community: what people commonly report, in which week, at which doses. We never publish individual quotes, names, screenshots, or personal data. The experience section is always marked separately from the official source.
We say what we do not know
If a question does not have a clear answer in the official prescribing information, we say so explicitly. If a topic needs medical assessment, we say: talk to your doctor or pharmacist. We do not invent an answer. We would rather leave a gap than fill it with assumptions.
We do not publish what could cause harm
Conversion tables for pen-splitting, dose-splitting instructions, medication combinations: we do not publish these, even when asked. We explain why and redirect to a pharmacist.
We re-verify quarterly
Prescribing information gets updated. Guidelines change. Every article has a verification date and we re-check them every 3 months.